M&A Deal Summary |
|
|---|---|
| Date | 2013-11-25 |
| Target | Jennerex Biotherapeutics |
| Sector | Life Science |
| Buyer(s) | SillaJen Biotherapeutics |
| Deal Type | Add-on Acquisition |
| Advisor(s) | Centerview Partners (Financial) Gunderson Dettmer (Legal) |
SEARCH BY
SillaJen Biotherapeutics is a specializing in the translational and clinical development of complex biologics. The SillaJen translational research, assay, and clinical research teams offer an array of services in a quality systems environment to bring investigational products from bench to bedside. Located on the campus of Pusan National University, the company is comprised of dedicated in-house teams that collaborate closely with a network of local and USA-based world-class scientists and physicians.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 1 of 1 |
| State: California M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2013 M&A | 1 of 1 |
